-
What will be the projected value of Oral Disintegrating Strip Market by 2035?
The Oral Disintegrating Strip Market is projected to reach USD 1817.85 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.
-
What is the expected CAGR of the Oral Disintegrating Strip Market during 2026-2035?
The Oral Disintegrating Strip Market is expected to grow at a CAGR of 10.28% during the forecast period from 2026 to 2035.
-
Which companies are leading the Oral Disintegrating Strip Market?
Key players in the Oral Disintegrating Strip Market market include BioDelivery(BDSI) (USA), LLS Health (USA), Tapemark (USA), Aavishkar (India), Shilpa Therapeutics (India), Adhex Pharma (France), Arx Pharma (France), Xiamen LP Pharma (China), Cure Pharmaceutical (USA), QQP (South Africa), Umang (India), Aquestive Therapeutics (USA), Top Pharm (Netherlands), NAL Pharma (China), ZIM Laboratories (India), LIVKON Pharmaceutical Pvt Ltd (India), IntelGenx Corp. (Canada), Johnson & Johnson (J&J) (USA), Lohmann Therapie-Systeme (Germany)
-
How large was the Oral Disintegrating Strip Market in 2025?
The Oral Disintegrating Strip Market was valued at USD 1229.05 Million in 2025, reflecting strong demand and continued adoption across major industries.